Aura Biosciences, Inc. (AURA) Financials

AURA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 179.8 million 28.0 million
2023-06-30 192.7 million 26.3 million
2023-03-31 206.0 million 25.8 million
2022-12-31 223.9 million 28.4 million

AURA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -15.5 million 2.3 million
2023-06-30 -14.8 million 1.9 million
2023-03-31 -16.5 million 1.9 million
2022-12-31 -18.4 million 1.8 million

AURA Net Income

No data available :(

AURA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 149.1 million - 20.2 million
2023-06-30 162.0 million - 20.4 million
2023-03-31 173.5 million - 20.6 million
2022-12-31 188.8 million - 20.9 million

AURA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 38.2 million
2023-06-30 37.9 million
2023-03-31 37.8 million
2022-12-31 29.9 million

AURA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 90000 15.4 million 5.1 million -
2023-06-30 193000 15.1 million 5.2 million -
2023-03-31 109000 14.4 million 5.0 million -
2022-12-31 358000 13.2 million 4.5 million -

AURA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 400000
2023-06-30 - 300000
2023-03-31 - 328000
2022-12-31 - 323000

AURA

Price: $7.89

52 week price:
5.99
13.50

Earnings Per Share: -1.95 USD

P/E Ratio: -4.10

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 120900

Market Capitalization: 380.0 million

Links: